These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 5374277)

  • 1. Heparin action on bleeding time and its rate of removal from blood in dogs and rabbits.
    Magalhães JR
    Acta Physiol Lat Am; 1969; 19(3):243-8. PubMed ID: 5374277
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-hemostatic action of heparin: relationship between topical and intravenous application.
    Magalhàes JR; Unglert CV; Damiani H; Nogueira Filho J
    Acta Physiol Lat Am; 1971; 21(3):209-15. PubMed ID: 5158678
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of levomycetin on blood coagulation and the sensitivity of animals to heparin].
    Zolotukhin SI; Ovchinnikova LK
    Farmakol Toksikol; 1970; 33(6):703-7. PubMed ID: 5518492
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of heparin on the plasma fibrinolytic activity.
    Poplawski A; Glowínski S
    Acta Physiol Pol; 1974; 25(1):39-42. PubMed ID: 4281609
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in blood coagulation and fibrinolysis on the intravenous administration of a parotid gland extract].
    Sakharov IuK
    Fiziol Zh (1978); 1979; 25(3):315-8. PubMed ID: 437187
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV; Ovchinnikova LK; Zolotukhin SI
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of prolonged hypocoagulation appearing after intratracheal administration of heparin].
    Efimov VS; Rumiantseva AG; Golovleva OA; Rozkin MIa
    Biull Eksp Biol Med; 1992 May; 113(5):509-12. PubMed ID: 1421273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Device for the determination of the electrophoretic mobility of cellular blood elements].
    Belokon AN; Popov MP; Gubarev EA; Lakin KM; Efimov VS
    Farmakol Toksikol; 1970; 33(5):634-8. PubMed ID: 5493230
    [No Abstract]   [Full Text] [Related]  

  • 9. [Action of an adrenaline-heparin complex on the blood in vivo].
    Liapina LA; Balakina TA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1974; 5():38-42. PubMed ID: 4275517
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversal of protamine of the prolonged response to intrapulmonary heparin.
    Wright CJ; Mahadoo J; Jaques LB
    Can J Surg; 1981 Mar; 24(2):130-2. PubMed ID: 7225967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy.
    Ray PK; Harper TA
    J Lab Clin Med; 1971 Jun; 77(6):901-7. PubMed ID: 5559859
    [No Abstract]   [Full Text] [Related]  

  • 12. [Action of heparin, adrenaline and an adrenaline-heparin complex on thrombocyte aggregation and on plasma lytic activity in animals].
    Kudriashov BA; Pastorova VE; Liapina LA
    Probl Gematol Pereliv Krovi; 1973 May; 18(5):28-33. PubMed ID: 4781491
    [No Abstract]   [Full Text] [Related]  

  • 13. [State of the blood coagulation and tissue blood coagulation factors in hypokinesia in heparinized rabbits].
    Sviridkina LP; Inchina VI; Grinevskaia IuI
    Kosm Biol Aviakosm Med; 1979; 13(4):87-9. PubMed ID: 459411
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of delagil on the blood coagulation system and the interrelation with heparin].
    Ovchinnikova LK; Pomortseva IV
    Farmakol Toksikol; 1985; 48(2):77-81. PubMed ID: 3996575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated coagulation time test: a convenient monitor of heparinization for dogs used in cardiovascular research.
    Wilkerson RD; Conran PB; Greene SL
    Lab Anim Sci; 1984 Feb; 34(1):62-5. PubMed ID: 6716959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The influence of ciprofloxacin and pefloxacin on blood coagulation and the anticoagulant effect of heparin].
    Lepakhin VK; Ushkalova EA; Shcheglova NV
    Farmakol Toksikol; 1989; 52(5):33-6. PubMed ID: 2599074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of regulating blood clotting with heparin and its antagonists on mast cells].
    Efimov VS; Rozkin MIa; Poberiĭ IA; Lindner DP
    Farmakol Toksikol; 1981; 44(1):80-5. PubMed ID: 7262304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R; Jacobs C
    Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One year of continuous heparinization in the dog using a totally implantable infusion pump.
    Blackshear PJ; Rohde TD; Varco RL; Buchwald H
    Surg Gynecol Obstet; 1975 Aug; 141(2):176-86. PubMed ID: 1154224
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of isoptin on the anticoagulant effect of the sodium and calcium salts of heparin].
    Ushkalova EA; Kremneva VF; Shcheglova NV
    Farmakol Toksikol; 1988; 51(3):48-51. PubMed ID: 3410026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.